New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva

Ipsen has just announced that they will be acquiring Clementia Pharmaceuticals. This merging of companies is exciting for the rare community because it will strengthen the resources, knowledge-base, and overall…

Continue Reading New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva

Updates From Spark Highlight the Potential of Gene Therapy for Treating Hemophilia

According to a story from Hemophilia News Today, the drug developer Spark Therapeutics, Inc., has recently released several updates in regards to a number of its experimental gene therapies that…

Continue Reading Updates From Spark Highlight the Potential of Gene Therapy for Treating Hemophilia

Phase 1b Trial for Lupus Nephritis Utilizing New Therapeutic Approach to Commence Soon

Lupus Nephritis Lupus nephritis (LN) is one of the most common complications of systemic lupus erythematosus (SLE). It affects approximately 100,000 patients in the United States alone. Basically, the patient's…

Continue Reading Phase 1b Trial for Lupus Nephritis Utilizing New Therapeutic Approach to Commence Soon